Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA-BN mpox vaccine study in adults and children
PACTR202501779440066Phase 2Recruiting
- Sponsor
- Bavarian Nordic
- Start
- Oct 2024
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 2 trial of JYNNEOS in mpox (2 cohorts), sponsored by Bavarian Nordic. Started Oct 2024; status: recruiting.
02
Drugs
JYNNEOS
03
Conditions
mpox
Beyond the preview
Go deeper on PACTR202501779440066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202501779440066.